Pharmacological modulation of nitric oxide synthesis by mechanism-based inactivators and related inhibitors
- 21 October 1999
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 84 (2) , 157-178
- https://doi.org/10.1016/s0163-7258(99)00030-3
Abstract
No abstract availableKeywords
This publication has 80 references indexed in Scilit:
- Mechanism of Inducible Nitric Oxide Synthase Inactivation by Aminoguanidine and l-N6-(1-Iminoethyl)lysineBiochemistry, 1998
- NO Synthase Isozymes Have Distinct Substrate Binding SitesBiochemistry, 1997
- Characterization of the Inducible Nitric Oxide Synthase Oxygenase Domain Identifies a 49 Amino Acid Segment Required for Subunit Dimerization and Tetrahydrobiopterin InteractionBiochemistry, 1997
- Active-Site Structure Analysis of Recombinant Human Inducible Nitric Oxide Synthase Using ImidazoleBiochemistry, 1996
- Interaction of Calmodulin with the Inducible Murine Macrophage Nitric Oxide SynthaseBiochemistry, 1995
- Nitric Oxide Synthase Inhibitors Preclinical Studies of Potential Use for Treatment of Opioid WithdrawalNeuropsychopharmacology, 1995
- Role of NO in vascular smooth muscle and cardiac muscle functionTrends in Pharmacological Sciences, 1994
- Regional distribution of EDRF/NO-synthesizing enzyme(s) in rat brainBiochemical and Biophysical Research Communications, 1990
- NG-Amino-L-arginine: A new potent antagonist of L-arginine-mediated endothelium-dependent relaxationBiochemical and Biophysical Research Communications, 1990
- Inactivation of cytochrome P‐450 and production of N‐alkylated porphyrins caused in isolated hepatocytes by substituted dihydropyridinesFEBS Letters, 1982